Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
The Journal of Biological Chemistry
|
August 30, 2000
Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells
F Chen, D S Yang, S Petanceska, et al.
Alimentary Pharmacology & Therapeutics
|
May 25, 2016
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
W J Sandborn, B R Bhandari, R Fogel, et al.
Nature Medicine
|
January 1, 1997
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
M Citron, D Westaway, W Xia, et al.
Gut
|
October 18, 2015
Development and validation of a histological index for UC
Mahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Brain Research. Molecular Brain Research
|
May 29, 1998
Amyloid-beta-protein isoforms in brain of subjects with PS1-linked, beta APP-linked and sporadic Alzheimer disease
A Tamaoka, P E Fraser, K Ishii, et al.
Nature Medicine
|
February 4, 1999
Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex
M Nishimura, G Yu, G Levesque, et al.
Gastroenterology
|
March 27, 2013
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Brian G Feagan, William J Sandborn, Geert D'Haens, et al.
Human Molecular Genetics
|
July 1, 1996
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
R Sherrington, S Froelich, S Sorbi, et al.
Gut
|
November 1, 2014
Reproducibility of histological assessments of disease activity in UC
Mahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Alimentary Pharmacology & Therapeutics
|
February 7, 2017
Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease
V Jairath, G Zou, C E Parker, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
The Journal of Biological Chemistry
|
August 30, 2000
Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells
F Chen, D S Yang, S Petanceska, et al.
Alimentary Pharmacology & Therapeutics
|
May 25, 2016
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
W J Sandborn, B R Bhandari, R Fogel, et al.
Nature Medicine
|
January 1, 1997
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
M Citron, D Westaway, W Xia, et al.
Gut
|
October 18, 2015
Development and validation of a histological index for UC
Mahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Brain Research. Molecular Brain Research
|
May 29, 1998
Amyloid-beta-protein isoforms in brain of subjects with PS1-linked, beta APP-linked and sporadic Alzheimer disease
A Tamaoka, P E Fraser, K Ishii, et al.
Nature Medicine
|
February 4, 1999
Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex
M Nishimura, G Yu, G Levesque, et al.
Gastroenterology
|
March 27, 2013
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Brian G Feagan, William J Sandborn, Geert D'Haens, et al.
Human Molecular Genetics
|
July 1, 1996
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
R Sherrington, S Froelich, S Sorbi, et al.
Gut
|
November 1, 2014
Reproducibility of histological assessments of disease activity in UC
Mahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Alimentary Pharmacology & Therapeutics
|
February 7, 2017
Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease
V Jairath, G Zou, C E Parker, et al.
Page
of 13